These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 22292757)
1. Chelating systems for (99m)Tc/(188)Re in the development of radiolabeled peptide pharmaceuticals. Bolzati C; Carta D; Salvarese N; Refosco F Anticancer Agents Med Chem; 2012 Jun; 12(5):428-61. PubMed ID: 22292757 [TBL] [Abstract][Full Text] [Related]
2. Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals. Bartholomä M; Valliant J; Maresca KP; Babich J; Zubieta J Chem Commun (Camb); 2009 Feb; (5):493-512. PubMed ID: 19283279 [TBL] [Abstract][Full Text] [Related]
3. A solid-phase labeling strategy for the preparation of technetium and rhenium bifunctional chelate complexes and associated peptide conjugates. Riddoch RW; Schaffer P; Valliant JF Bioconjug Chem; 2006; 17(1):226-35. PubMed ID: 16417273 [TBL] [Abstract][Full Text] [Related]
4. Isothiocyanate-Functionalized Bifunctional Chelates and fac-[M(I)(CO)3](+) (M = Re, (99m)Tc) Complexes for Targeting uPAR in Prostate Cancer. Kasten BB; Ma X; Cheng K; Bu L; Slocumb WS; Hayes TR; Trabue S; Cheng Z; Benny PD Bioconjug Chem; 2016 Jan; 27(1):130-42. PubMed ID: 26603218 [TBL] [Abstract][Full Text] [Related]
5. Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods. Eberle AN; Mild G J Recept Signal Transduct Res; 2009; 29(1):1-37. PubMed ID: 19519167 [TBL] [Abstract][Full Text] [Related]
6. NOTA and NODAGA [ Makris G; Radford LL; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM Bioconjug Chem; 2018 Dec; 29(12):4040-4049. PubMed ID: 30412382 [TBL] [Abstract][Full Text] [Related]
7. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. Polyakov V; Sharma V; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D Bioconjug Chem; 2000; 11(6):762-71. PubMed ID: 11087323 [TBL] [Abstract][Full Text] [Related]
8. Dual-targeting conjugates designed to improve the efficacy of radiolabeled peptides. Kluba CA; Bauman A; Valverde IE; Vomstein S; Mindt TL Org Biomol Chem; 2012 Oct; 10(37):7594-602. PubMed ID: 22898743 [TBL] [Abstract][Full Text] [Related]
9. Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy. Goins B; Bao A; Phillips WT Methods Mol Biol; 2017; 1522():155-178. PubMed ID: 27837538 [TBL] [Abstract][Full Text] [Related]
10. Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals. Tisato F; Bolzati C; Porchia M; Refosco F Mass Spectrom Rev; 2004; 23(5):309-32. PubMed ID: 15264232 [TBL] [Abstract][Full Text] [Related]
11. Tetraamine-coupled peptides and resulting (99m)Tc-radioligands: an effective route for receptor-targeted diagnostic imaging of human tumors. Nock B; Maina T Curr Top Med Chem; 2012; 12(23):2655-67. PubMed ID: 23339761 [TBL] [Abstract][Full Text] [Related]
12. Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals. Khan IU; Beck-Sickinger AG Anticancer Agents Med Chem; 2008 Feb; 8(2):186-99. PubMed ID: 18288921 [TBL] [Abstract][Full Text] [Related]
13. A new strategy for the preparation of peptide-targeted technetium and rhenium radiopharmaceuticals. The automated solid-phase synthesis, characterization, labeling, and screening of a peptide-ligand library targeted at the formyl peptide receptor. Stephenson KA; Banerjee SR; Sogbein OO; Levadala MK; McFarlane N; Boreham DR; Maresca KP; Babich JW; Zubieta J; Valliant JF Bioconjug Chem; 2005; 16(5):1189-95. PubMed ID: 16173797 [TBL] [Abstract][Full Text] [Related]
14. Development and Pharmacological Evaluation of New Bone-Targeted (99m)Tc-Radiolabeled Bisphosphonates. Makris G; Tseligka ED; Pirmettis I; Papadopoulos MS; Vizirianakis IS; Papagiannopoulou D Mol Pharm; 2016 Jul; 13(7):2301-17. PubMed ID: 27170456 [TBL] [Abstract][Full Text] [Related]
16. Techniques for loading technetium-99m and rhenium-186/188 radionuclides into pre-formed liposomes for diagnostic imaging and radionuclide therapy. Goins B; Bao A; Phillips WT Methods Mol Biol; 2010; 606():469-91. PubMed ID: 20013416 [TBL] [Abstract][Full Text] [Related]
17. A different 'spin' on rhenium chemistry. synthetic approaches and perspectives of 17-electron rhenium complexes. Zobi F Chimia (Aarau); 2010; 64(4):259-65. PubMed ID: 21138193 [TBL] [Abstract][Full Text] [Related]
18. Cyclic-RGD penta-peptides cRGDyK derivatized with cyclopentadienyl complexes of technetium and rhenium as radiopharmaceutical probes. Nadeem Q; Shen Y; Warsi MF; Nasar G; Qadir MA; Alberto R J Labelled Comp Radiopharm; 2017 Jul; 60(9):394-400. PubMed ID: 28430366 [TBL] [Abstract][Full Text] [Related]
19. Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer. Okarvi SM Cancer Treat Rev; 2008 Feb; 34(1):13-26. PubMed ID: 17870245 [TBL] [Abstract][Full Text] [Related]
20. Preparation and first biological evaluation of novel Re-188/Tc-99m peptide conjugates with substance-P. Smilkov K; Janevik E; Guerrini R; Pasquali M; Boschi A; Uccelli L; Di Domenico G; Duatti A Appl Radiat Isot; 2014 Sep; 92():25-31. PubMed ID: 24973465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]